107 related articles for article (PubMed ID: 23665252)
1. Imatinib methanesulfonate reduces hippocampal amyloid-β and restores cognitive function following repeated endotoxin exposure.
Weintraub MK; Bisson CM; Nouri JN; Vinson BT; Eimerbrink MJ; Kranjac D; Boehm GW; Chumley MJ
Brain Behav Immun; 2013 Oct; 33():24-8. PubMed ID: 23665252
[TBL] [Abstract][Full Text] [Related]
2. Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse.
Kahn MS; Kranjac D; Alonzo CA; Haase JH; Cedillos RO; McLinden KA; Boehm GW; Chumley MJ
Behav Brain Res; 2012 Apr; 229(1):176-84. PubMed ID: 22249135
[TBL] [Abstract][Full Text] [Related]
3. Imatinib methanesulfonate reduces hyperphosphorylation of tau following repeated peripheral exposure to lipopolysaccharide.
Gardner LE; White JD; Eimerbrink MJ; Boehm GW; Chumley MJ
Neuroscience; 2016 Sep; 331():72-7. PubMed ID: 27320209
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N
J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999
[TBL] [Abstract][Full Text] [Related]
5. The α5-GABA
Eimerbrink MJ; Pendry RJ; Hodges SL; Wiles JD; Peterman JL; White JD; Hayes HB; Chumley MJ; Boehm GW
Behav Brain Res; 2019 Feb; 359():871-877. PubMed ID: 30031883
[TBL] [Abstract][Full Text] [Related]
6. Peripheral administration of poly I:C leads to increased hippocampal amyloid-beta and cognitive deficits in a non-transgenic mouse.
Weintraub MK; Kranjac D; Eimerbrink MJ; Pearson SJ; Vinson BT; Patel J; Summers WM; Parnell TB; Boehm GW; Chumley MJ
Behav Brain Res; 2014 Jun; 266():183-7. PubMed ID: 24631395
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone and Aβ₂₅-₃₅ accelerate learning and memory impairments due to elevate amyloid precursor protein expression and neuronal apoptosis in 12-month male rats.
Li WZ; Li WP; Huang DK; Kan HW; Wang X; Wu WY; Yin YY; Yao YY
Behav Brain Res; 2012 Feb; 227(1):142-9. PubMed ID: 22061800
[TBL] [Abstract][Full Text] [Related]
8. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
9. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
10. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
12. The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's disease.
Meunier J; Villard V; Givalois L; Maurice T
Eur J Pharmacol; 2013 Jan; 698(1-3):193-9. PubMed ID: 23123349
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
14. Thiamine deficiency increases β-secretase activity and accumulation of β-amyloid peptides.
Zhang Q; Yang G; Li W; Fan Z; Sun A; Luo J; Ke ZJ
Neurobiol Aging; 2011 Jan; 32(1):42-53. PubMed ID: 19233513
[TBL] [Abstract][Full Text] [Related]
15. Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
Chen X; Hu J; Jiang L; Xu S; Zheng B; Wang C; Zhang J; Wei X; Chang L; Wang Q
Neuroscience; 2014 Oct; 279():94-101. PubMed ID: 25193238
[TBL] [Abstract][Full Text] [Related]
16. Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice.
Kawahara K; Suenobu M; Yoshida A; Koga K; Hyodo A; Ohtsuka H; Kuniyasu A; Tamamaki N; Sugimoto Y; Nakayama H
Neuroscience; 2012 Apr; 207():243-60. PubMed ID: 22342341
[TBL] [Abstract][Full Text] [Related]
17. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
[TBL] [Abstract][Full Text] [Related]
18. Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.
He G; Luo W; Li P; Remmers C; Netzer WJ; Hendrick J; Bettayeb K; Flajolet M; Gorelick F; Wennogle LP; Greengard P
Nature; 2010 Sep; 467(7311):95-8. PubMed ID: 20811458
[TBL] [Abstract][Full Text] [Related]
19. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
Ohno M; Hiraoka Y; Lichtenthaler SF; Nishi K; Saijo S; Matsuoka T; Tomimoto H; Araki W; Takahashi R; Kita T; Kimura T; Nishi E
Neurobiol Aging; 2014 Jan; 35(1):213-22. PubMed ID: 23954170
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]